MD vs RDNT
As of Sep 20, 2026, Pediatrix Medical Group (MD) scores 6.9/10 and RadNet (RDNT) 4.6/10 on AlphaStocks' five-model composite, so MD scores higher. MD trades 25% below its model fair value; RDNT trades 66% above its model fair value.
MD
Pediatrix Medical Group, Inc.
6.9
Consider Buy
$25.93
RDNT
RadNet, Inc.
4.6
Weak
$75.97
MD vs RDNT: Which is the Better Investment?
Pediatrix Medical Group, Inc. (MD) scores 6.9/10 while RadNet, Inc. (RDNT) scores 4.6/10 on AlphaStocks' composite model. Pediatrix Medical Group, Inc. has the higher composite rating of Consider Buy. Pediatrix Medical Group, Inc. trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | MD | RDNT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.9/10▲ | 4.6/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $25.93 | $75.97 |
| P/E Ratio | 13.4 | — |
| ROE | 18.8%▲ | -1.7% |
| Market Cap | $2B | $6B |
| Fair Value | $34.74 | $45.80 |
| Dividend Yield | — | — |
| Sector Rank | #17 of 168▲ | #124 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive▲ | Neutral |
| Buffett | Attractive▲ | Caution |
| Graham | Caution | Caution |
| Lynch | Neutral▲ | Caution |
| Greenblatt | Strong▲ | Neutral |
Related comparisons
MD vs RDNT: Which Stock Scores Higher?
Pediatrix Medical Group, Inc. (MD) and RadNet, Inc. (RDNT) are both in the Health Care sector. MD currently leads with a composite score of 6.9/10 (Consider Buy) compared to RDNT's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer